Cambrian BioPharma Inc's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed Dec 8, 2025
- Accession no.
- 0000897069-25-001776
- Filed
- Dec 8, 2025
- Trade date
- Dec 4-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $232.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cambrian BioPharma IncCIK 0001797409 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | Common Stock | SSaleDisposed | −5,000 | $9.06 | −$45,300 | 177,654 | Direct | Duplicate filing |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −14,508 | $11.40 | −$165,391.2 | 163,146 | Direct | Duplicate filing |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −1,745 | $12.29 | −$21,446.05 | 161,401 | Direct | Duplicate filing |
| Dec 5, 2025 | Common Stock | SSaleDisposed | −42 | $13.16 | −$552.72 | 161,359 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.